Serveur d'exploration sur les dispositifs haptiques

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.

Identifieur interne : 001795 ( PubMed/Corpus ); précédent : 001794; suivant : 001796

Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.

Auteurs : K A Becker ; M. Martin ; T M Rabsilber ; B B Entz ; A J Reuland ; G U Auffarth

Source :

RBID : pubmed:16687454

English descriptors

Abstract

Owing to the improvement of modern intraocular lenses (IOLs) in terms of design and material, posterior capsule opacification (PCO) usually takes 2-3 years to develop. Thus, long term clinical evaluation of new implants is important.

DOI: 10.1136/bjo.2006.092437
PubMed: 16687454

Links to Exploration step

pubmed:16687454

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.</title>
<author>
<name sortKey="Becker, K A" sort="Becker, K A" uniqKey="Becker K" first="K A" last="Becker">K A Becker</name>
<affiliation>
<nlm:affiliation>Heidelberg IOL and Refractive Surgery Research Group, Department of Ophthalmology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Martin, M" sort="Martin, M" uniqKey="Martin M" first="M" last="Martin">M. Martin</name>
</author>
<author>
<name sortKey="Rabsilber, T M" sort="Rabsilber, T M" uniqKey="Rabsilber T" first="T M" last="Rabsilber">T M Rabsilber</name>
</author>
<author>
<name sortKey="Entz, B B" sort="Entz, B B" uniqKey="Entz B" first="B B" last="Entz">B B Entz</name>
</author>
<author>
<name sortKey="Reuland, A J" sort="Reuland, A J" uniqKey="Reuland A" first="A J" last="Reuland">A J Reuland</name>
</author>
<author>
<name sortKey="Auffarth, G U" sort="Auffarth, G U" uniqKey="Auffarth G" first="G U" last="Auffarth">G U Auffarth</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="doi">10.1136/bjo.2006.092437</idno>
<idno type="RBID">pubmed:16687454</idno>
<idno type="pmid">16687454</idno>
<idno type="wicri:Area/PubMed/Corpus">001795</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.</title>
<author>
<name sortKey="Becker, K A" sort="Becker, K A" uniqKey="Becker K" first="K A" last="Becker">K A Becker</name>
<affiliation>
<nlm:affiliation>Heidelberg IOL and Refractive Surgery Research Group, Department of Ophthalmology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Martin, M" sort="Martin, M" uniqKey="Martin M" first="M" last="Martin">M. Martin</name>
</author>
<author>
<name sortKey="Rabsilber, T M" sort="Rabsilber, T M" uniqKey="Rabsilber T" first="T M" last="Rabsilber">T M Rabsilber</name>
</author>
<author>
<name sortKey="Entz, B B" sort="Entz, B B" uniqKey="Entz B" first="B B" last="Entz">B B Entz</name>
</author>
<author>
<name sortKey="Reuland, A J" sort="Reuland, A J" uniqKey="Reuland A" first="A J" last="Reuland">A J Reuland</name>
</author>
<author>
<name sortKey="Auffarth, G U" sort="Auffarth, G U" uniqKey="Auffarth G" first="G U" last="Auffarth">G U Auffarth</name>
</author>
</analytic>
<series>
<title level="j">The British journal of ophthalmology</title>
<idno type="ISSN">0007-1161</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acrylic Resins</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Biocompatible Materials</term>
<term>Cataract (etiology)</term>
<term>Endothelial Cells (pathology)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Laser Therapy</term>
<term>Lens Capsule, Crystalline (pathology)</term>
<term>Lens Capsule, Crystalline (surgery)</term>
<term>Lenses, Intraocular</term>
<term>Male</term>
<term>Materials Testing</term>
<term>Middle Aged</term>
<term>Postoperative Complications</term>
<term>Prospective Studies</term>
<term>Prosthesis Design</term>
<term>Recurrence</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Acrylic Resins</term>
<term>Biocompatible Materials</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Cataract</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Endothelial Cells</term>
<term>Lens Capsule, Crystalline</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Lens Capsule, Crystalline</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Laser Therapy</term>
<term>Lenses, Intraocular</term>
<term>Male</term>
<term>Materials Testing</term>
<term>Middle Aged</term>
<term>Postoperative Complications</term>
<term>Prospective Studies</term>
<term>Prosthesis Design</term>
<term>Recurrence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Owing to the improvement of modern intraocular lenses (IOLs) in terms of design and material, posterior capsule opacification (PCO) usually takes 2-3 years to develop. Thus, long term clinical evaluation of new implants is important.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">16687454</PMID>
<DateCreated>
<Year>2006</Year>
<Month>07</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2006</Year>
<Month>08</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0007-1161</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>90</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2006</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The British journal of ophthalmology</Title>
<ISOAbbreviation>Br J Ophthalmol</ISOAbbreviation>
</Journal>
<ArticleTitle>Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.</ArticleTitle>
<Pagination>
<MedlinePgn>971-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Owing to the improvement of modern intraocular lenses (IOLs) in terms of design and material, posterior capsule opacification (PCO) usually takes 2-3 years to develop. Thus, long term clinical evaluation of new implants is important.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">As part of a prospective, non-randomised FDA trial, the Rayner Centerflex, a foldable hydrophilic acrylic, single piece IOL was implanted in one eye of 83 patients (mean age 73.5 (SD 7.0) years). Over 3 years postoperatively, a standardised FDA protocol concerning IOL safety and efficacy was followed including evaluation of spherical equivalent (SE), best corrected distance visual acuity (BCDVA), endothelial cell count (ECC), flare meter values, PCO development, and anterior capsule shrinkage.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Postoperatively, mean SE was stable ranging between -0.3D and 0.17D. After 1-2 months, all patients achieved a BCDVA of 20/40 or better. At 3-6 months postoperatively, mean ECC decreased from 2612 (SD 346) cells/mm2 to 2380 (316) cells/mm2. Mean PCO score for the entire optic increased from 0.20 (0.20) months (3-6 months postoperatively) to 0.87 (0.57) resulting in a Nd:YAG rate of 29.41% after 3 years. No anterior capsule shrinkage was found.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The Centerflex showed excellent functional results, low values for endothelial cell loss and inflammatory signs, and no anterior capsule shrinkage. PCO formation was higher compared to other IOLs, which could be explained by the incomplete sharp edge at the optic-haptic junctions representing an "Achilles' heel" for cell ingrowth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Becker</LastName>
<ForeName>K A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Heidelberg IOL and Refractive Surgery Research Group, Department of Ophthalmology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rabsilber</LastName>
<ForeName>T M</ForeName>
<Initials>TM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Entz</LastName>
<ForeName>B B</ForeName>
<Initials>BB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reuland</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Auffarth</LastName>
<ForeName>G U</ForeName>
<Initials>GU</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2006</Year>
<Month>05</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Br J Ophthalmol</MedlineTA>
<NlmUniqueID>0421041</NlmUniqueID>
<ISSNLinking>0007-1161</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000180">Acrylic Resins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Ophthalmologe. 2005 Jun;102(6):579-86</RefSource>
<PMID Version="1">15889259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2004 Nov;30(11):2403-9</RefSource>
<PMID Version="1">15519096</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2005 Dec;31(12):2369-74</RefSource>
<PMID Version="1">16473233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eye (Lond). 1999 Jun;13 ( Pt 3b):489-92</RefSource>
<PMID Version="1">10627830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2000 Feb;26(2):180-7</RefSource>
<PMID Version="1">10683785</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2000 Feb;26(2):188-97</RefSource>
<PMID Version="1">10683786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2000 Feb;26(2):198-213</RefSource>
<PMID Version="1">10683787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2000 Apr;26(4):566-70</RefSource>
<PMID Version="1">10771231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2000 Oct;26(10):1543-9</RefSource>
<PMID Version="1">11033405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2001 Apr;27(4):608-13</RefSource>
<PMID Version="1">11311632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2001 Oct;27(10):1662-9</RefSource>
<PMID Version="1">11687368</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2002 Jan;28(1):50-61</RefSource>
<PMID Version="1">11777710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eye (Lond). 2002 May;16(3):217-41</RefSource>
<PMID Version="1">12032712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2002 Jul;28(7):1105-11</RefSource>
<PMID Version="1">12106717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2002 Jul;28(7):1141-52</RefSource>
<PMID Version="1">12106722</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2002 Jul;28(7):1241-50</RefSource>
<PMID Version="1">12106735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2002 Jul;28(7):1251-5</RefSource>
<PMID Version="1">12106736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2003 Feb;29(2):348-53</RefSource>
<PMID Version="1">12648648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ophthalmology. 2003 Apr;110(4):772-80</RefSource>
<PMID Version="1">12689901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Ophthalmol. 2003 Oct;136(4):614-9</RefSource>
<PMID Version="1">14516800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surv Ophthalmol. 2003 Nov-Dec;48(6):594-612</RefSource>
<PMID Version="1">14609706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Ophthalmol. 2004 Feb;137(2):377-9</RefSource>
<PMID Version="1">14962444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 2004 Apr;30(4):786-9</RefSource>
<PMID Version="1">15093639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Ophthalmol. 2004 Jun;88(6):746-9</RefSource>
<PMID Version="1">15148204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Indian J Ophthalmol. 2004 Jun;52(2):99-112</RefSource>
<PMID Version="1">15283214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surv Ophthalmol. 1992 Sep-Oct;37(2):73-116</RefSource>
<PMID Version="1">1455302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ophthalmologe. 1994 Oct;91(5):680-4</RefSource>
<PMID Version="1">7812105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 1996 Jan-Feb;22(1):63-71</RefSource>
<PMID Version="1">8656366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 1997 May;23(4):536-44</RefSource>
<PMID Version="1">9209988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ophthalmologe. 1997 Jul;94(7):515-8</RefSource>
<PMID Version="1">9333399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ophthalmic Surg Lasers. 1998 Jul;29(7):587-94</RefSource>
<PMID Version="1">9674010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 1999 Jan;25(1):106-17</RefSource>
<PMID Version="1">9888086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cataract Refract Surg. 1999 Apr;25(4):521-6</RefSource>
<PMID Version="1">10198857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ophthalmologe. 2005 Jun;102(6):572-8</RefSource>
<PMID Version="1">15895236</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000180">Acrylic Resins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001672">Biocompatible Materials</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002386">Cataract</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042783">Endothelial Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053685">Laser Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007903">Lens Capsule, Crystalline</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007910">Lenses, Intraocular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008422">Materials Testing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011474">Prosthesis Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC1857197</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="aheadofprint">
<Year>2006</Year>
<Month>5</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>5</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>8</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2006</Year>
<Month>5</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pii">bjo.2006.092437</ArticleId>
<ArticleId IdType="doi">10.1136/bjo.2006.092437</ArticleId>
<ArticleId IdType="pubmed">16687454</ArticleId>
<ArticleId IdType="pmc">PMC1857197</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001795 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001795 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    HapticV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:16687454
   |texte=   Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:16687454" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a HapticV1 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Mon Jun 13 01:09:46 2016. Site generation: Wed Mar 6 09:54:07 2024